BYU Researchers Develop Method for Efficient Creation of Type 2 Diabetes Drugs
A group of Brigham Young University chemists has developed a cheaper, more efficient way of producing a synthetic molecule that is widely used in modern prescription drugs.
The team was led by BYU chemistry professor Merritt Andrus, who worked with graduate student Erik Hicken and undergraduate students Jeff Stevens and Karl Bedke.
Their discovery could have broad implications in the discovery, production, and possibly the cost of many forthcoming drugs.
Many next-generation prescription drugs, currently in the trial phase of development, rely on chiral molecules, which allow a drug to specifically target infected protein chains in the body and directly treat them.
Read the full press release here.